Aerie wins FDA nod for second glaucoma drug

Aerie Pharmaceuticals - updated logoAerie Pharmaceuticals (NSDQ:AERI) said this week that the FDA approved the company’s once-daily eye drop Rocklatan for the treatment of elevated intraocular pressure in people with open-angle glaucoma or ocular hypertension.

The Durham, N.C.-based company’s product is a fixed-dose combination of latanoprost and netarsudil – the active ingredient in Aerie’s first drug, Rhopressa.

Get the full story at our sister site, Drug Delivery Business News.

The post Aerie wins FDA nod for second glaucoma drug appeared first on MassDevice.

Aerie expands drug-delivery tech deal with DSM Biomedical

Aerie Pharmaceuticals (NSDQ:AERI) said today that it expanded its drug-delivery R&D deal with DSM Biomedical.

The two companies first joined forces in July last year to evaluate the sustained delivery of certain Aerie drugs using DSM’s polymer technology. Initially, the group was focused on developing drug-delivery tech for people with wet age-related macular degeneration and diabetic macular edema.

Get the full story at our sister site, Drug Delivery Business News.

The post Aerie expands drug-delivery tech deal with DSM Biomedical appeared first on MassDevice.

SureFire Medical names pharma vet Szela as president, CEO | Personnel Moves – Jan. 26, 2018


SureFire Medical has named pharma veteran Mary Szela as its president, CEO and board member, succeeding founder James Chomas, who has served as the company’s chief executive and president since 2009.

Chomas will assume the role of chief technology officer and oncology strategy officer, focusing his efforts on the the company’s oncology drug-delivery tech.

Get the full story at our sister site, Drug Delivery Business News.

OncoSec Medical names new CEO | Personnel Moves – Nov. 9, 2017


OncoSec MedicalOncoSec Medical (NSDQ:ONCS)  announced earlier this week that the company’s co-founder, Punit Dhillon, would step down as CEO and continue to serve as president while Daniel O’Connor takes over the corner office.

O’Connor joined OncoSec’s board of directors in September this year.

“We are pleased to welcome Dan to OncoSec at this important time, and believe he is uniquely qualified to lead the company through the successful completion of its phase IIb registration directed trial, Pisces/Keynote-695 in patients with unresectable metastatic melanoma who have progressed or are progressing on an anti-PD-1 therapy,” chairman Avtar Dhillon said in prepared remarks. “Dan is a proven leader with a strong track record of success and brings exceptional strategic and operational expertise in building thriving, successful biopharma companies.”

Get the full story at our sister site, Drug Delivery Business News.

Aerie Pharmaceuticals misses EPS estimates by 7 cents in Q3

  • Medical device design transfer: 5 things you need to know

    Moving from design to production can be a challenging process in the medical device industry. Take these points into consideration to enable a smooth design transfer. Charlie Sears, Goddard Technologies There are many publications that discuss product development; however, an area that I find challenging within medical device companies is effectively transferring a product from […]

  • EQT acquires Clinical Innovations

    EQT Mid Market US fund has acquired a majority stake in the company Clinical Innovations. Financial details of the deal were not immediately disclosed. Clinical Innovations recently expanded its product portfolio to serve the neonatal intensive care unit. Headquartered in Salt Lake City, it develops products like the Kiwi vacuum-assisted delivery system and Koala intrauterine […]

  • What you need to know about Europe’s new medical device rules

    New regulations are coming to the European Union, and it’s up to developers to implement changes that will help them thrive in the new environment. Vicki Anastasi, Icon The new European Medical Devices Regulation (MDR) and the In Vitro Diagnostic Medical Devices Regulation (IVDR) represent one of the most wide-ranging and disruptive changes to recently […]

  • Medical device cybersecurity: Here’s how you verify and validate it

    Cybersecurity is becoming an essential pillar of medical device design, and it’s important to find the right strategies to validate and verify your products are secure. Michael Lynch and Delmar Howard, Intertek The growth of connected environments has put medical devices at the forefront of the cybersecurity and patient data movement. As more of these […]

  • Siemens Healthineers launches Share360 clinical engineering support platform

    Siemens (NYSE:SI) Healthineers said today it launched the Share360 in-house service portfolio designed to support clinical engineering departments with customizable levels of support. The newly launched Share360 portfolio is intended to support customer service strategies by letting users customize the level of collaboration with Siemens they need, as well as optimizing workforce utilization, the company said. “With the […]

  • How a versatile epoxy is enabling brain stimulation

    In but another example of how useful and critical epoxies can be, researchers in Israel used a two-part epoxy to construct a magnetic coil to stimulate animal brain neurons via a magnetic field. Rohit Ramnath, Master Bond Designers of medical electronics assemblies have many options to choose from when selecting one or more compounds for […]

  • Pros and cons of MDNR and MDMA medical device registration in Saudi Arabia

    By Stewart Eisenhart, Emergo Group Now that Saudi Arabian medical device regulators have exempted some low-risk products from full registration requirements, qualifying manufacturers should consider whether standard or fast-track access to the Saudi market best suits their business needs. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog […]

  • FDA puts Second Sight Medical’s next-gen Orion ‘bionic eye’ on the fast track

    Second Sight Medical (NSDQ:EYES) said today that the FDA put its Orion “bionic eye” on the fast track to approval. The Orion device is a cortical visual prosthesis that uses a camera and a brain implant to bypass the optic nerve in visually impaired patients. The federal safety watchdog put the device on its expedited […]

  • Intuitive Surgical opens Korean innovation, training center

    Robotic surgical giant Intuitive Surgical (NSDQ:ISRG) opened the doors this week on a new $8.9 million surgical innovation training center on South Korea, according to a Korea Herald report. The new 39,008-square-foot center is located inside the Sangam DMC High-Tech Industry Center in Seoul and features five training stations with a total of seven da Vinci systems, […]

  • Middleware: How it’s changing medtech

    Medtech developers can take advantage of middleware technology to gain a competitive advantage. Tim Gee, Medical Connectivity Consulting Two macro trends are affecting how medical devices and systems are designed: Adoption of off-the-shelf (OTS) computing technology to extend the power and capabilities of traditional embedded system medical devices; and the evolution of software architectures that greatly […]

  • How have medtech launches and prototyping evolved with 3D printing?

    Here are three basic ways that 3D printing can help you get your medical device project off the ground. Jim Medsker, Keystone Solutions Group Additive manufacturing, commonly referred to as 3D printing, began to surface in the 1980s. Since then, the technology has quickly become a valuable tool for creating plastic prototype parts in a rapid […]